Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders

 
 

KING PHARMACEUTICALS INC (KG) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $0.15 Metrics
OS: 250.0 M 3 % ROE
Market cap: $36.2 M 11 % ROIC
Net cash: $503 M $2.01 per share
EV:

 
TTM Valuation
EBITDA $414 M -1.1 x EV/EBITDA
EBIT $200 M -2.3 x EV/EBIT
EPS $0.34 0.4 x P/E

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-09Dec-31-08Dec-31-07Dec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
Revenues1,776.51,565.12,136.91,988.51,772.91,304.41,492.81,088.0
            Revenue growth13.5%-26.8%7.5%12.2%35.9%-12.6%37.2%24.7%
Cost of goods sold616.0991.9601.8529.8510.0359.7567.8309.2
Gross profit1,160.5573.11,535.01,458.71,262.9944.7925.0778.9
            Gross margin65.3%36.6%71.8%73.4%71.2%72.4%62.0%71.6%
Selling, general and administrative548.6447.4691.0714.0636.5595.4490.6357.4
Research and development98.7145.2149.4143.674.067.944.128.2
EBIT298.8-170.9520.2453.6407.0128.7288.6341.9
            EBIT margin16.8%-10.9%24.3%22.8%23.0%9.9%19.3%31.4%
Pre-tax income150.6-216.2238.4424.3178.1-58.0163.3248.5
Income taxes58.6125.962.9135.761.5-7.465.978.0
            Tax rate38.9% 26.4%32.0%34.5%12.8%40.3%31.4%
Earnings from continuing ops92.0-342.0175.5288.6116.6-50.697.4170.5
Earnings from discontinued ops  -0.20.41.2-63.1-3.37.0
Net income92.0-342.0175.2288.9117.8-160.392.0182.4
            Net margin5.2%-21.9%8.2%14.5%6.6%-12.3%6.2%16.8%
 
Diluted EPS$0.37($1.40)$0.72$242,505.88$0.48($0.21)$0.40$0.69
Shares outstanding (diluted)248.5244.3243.40.0240.5242.9242.0246.5
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy